This manuscript builds on our initial observation that ASO-mediated knockdown of Mboat7 promotes NAFLD progression, hyperinsulinemia, and insulin resistance in mice (Gwag et al., 2019). The gene discussed is MBOAT7; the disease is metabolic dysfunction-associated steatotic liver disease.